日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Neoadjuvant Nivolumab Plus Ipilimumab Versus Chemotherapy in Resectable Lung Cancer

可切除肺癌新辅助治疗中,纳武利尤单抗联合伊匹木单抗与化疗的比较

Awad, Mark M; Forde, Patrick M; Girard, Nicolas; Spicer, Jonathan; Wang, Changli; Lu, Shun; Mitsudomi, Tetsuya; Felip, Enriqueta; Broderick, Stephen R; Swanson, Scott J; Brahmer, Julie; Kerr, Keith; Saylors, Gene B; Chen, Ke-Neng; Gharpure, Vishwanath; Neely, Jaclyn; Balli, David; Hu, Nan; Provencio Pulla, Mariano

Pretreatment and on-treatment ctDNA and tissue biomarkers predict recurrence in patients with stage IIIB-D/IV melanoma treated with adjuvant immunotherapy: CheckMate 915

治疗前和治疗期间的ctDNA和组织生物标志物可预测接受辅助免疫疗法治疗的IIIB-D/IV期黑色素瘤患者的复发:CheckMate 915

Long, Georgina V; Tang, Hao; Desai, Keyur; Wang, Sheen; Del Vecchio, Michele; Larkin, James; Ritchings, Corey; Huang, Shu-Pang; Baden, Jonathan; Balli, David; Chang, Han; Fusaro, Gina; Tenney, Daniel; Dolfi, Sonia; Weber, Jeffrey

LRP1b Loss Predicts Sensitivity to Immunotherapy in Patients with NSCLC: An Analysis of the Phase III CheckMate-026 Randomized Trial

LRP1b缺失可预测非小细胞肺癌患者对免疫疗法的敏感性:一项基于III期CheckMate-026随机试验的分析

Armstrong, Andrew J; Dietz, Hilary; Balli, David; Geese, William J; Duan, Chunzhe; Hung, Yu-Han; Ip, Virginia; Li, Gerald; Graf, Ryon P; Ready, Neal

Association between pathologic response and survival after neoadjuvant therapy in lung cancer

肺癌新辅助治疗后病理反应与生存率的关系

Deutsch, Julie Stein; Cimino-Mathews, Ashley; Thompson, Elizabeth; Provencio, Mariano; Forde, Patrick M; Spicer, Jonathan; Girard, Nicolas; Wang, Daphne; Anders, Robert A; Gabrielson, Edward; Illei, Peter; Jedrych, Jaroslaw; Danilova, Ludmila; Sunshine, Joel; Kerr, Keith M; Tran, Mia; Bushong, Judith; Cai, Junliang; Devas, Vipul; Neely, Jaclyn; Balli, David; Cottrell, Tricia R; Baras, Alex S; Taube, Janis M

Deep computational image analysis of immune cell niches reveals treatment-specific outcome associations in lung cancer

对免疫细胞微环境进行深度计算图像分析,揭示肺癌治疗特异性结果关联

Barrera, Cristian; Corredor, Germán; Viswanathan, Vidya Sankar; Ding, Ruiwen; Toro, Paula; Fu, Pingfu; Buzzy, Christina; Lu, Cheng; Velu, Priya; Zens, Philipp; Berezowska, Sabina; Belete, Merzu; Balli, David; Chang, Han; Baxi, Vipul; Syrigos, Konstantinos; Rimm, David L; Velcheti, Vamsidhar; Schalper, Kurt; Romero, Eduardo; Madabhushi, Anant

Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer

可切除肺癌的新辅助治疗:纳武利尤单抗联合化疗

Forde, Patrick M; Spicer, Jonathan; Lu, Shun; Provencio, Mariano; Mitsudomi, Tetsuya; Awad, Mark M; Felip, Enriqueta; Broderick, Stephen R; Brahmer, Julie R; Swanson, Scott J; Kerr, Keith; Wang, Changli; Ciuleanu, Tudor-Eliade; Saylors, Gene B; Tanaka, Fumihiro; Ito, Hiroyuki; Chen, Ke-Neng; Liberman, Moishe; Vokes, Everett E; Taube, Janis M; Dorange, Cecile; Cai, Junliang; Fiore, Joseph; Jarkowski, Anthony; Balli, David; Sausen, Mark; Pandya, Dimple; Calvet, Christophe Y; Girard, Nicolas

Image analysis reveals molecularly distinct patterns of TILs in NSCLC associated with treatment outcome

图像分析揭示了非小细胞肺癌中肿瘤浸润淋巴细胞(TILs)的分子特征模式与治疗结果相关

Ding, Ruiwen; Prasanna, Prateek; Corredor, Germán; Barrera, Cristian; Zens, Philipp; Lu, Cheng; Velu, Priya; Leo, Patrick; Beig, Niha; Li, Haojia; Toro, Paula; Berezowska, Sabina; Baxi, Vipul; Balli, David; Belete, Merzu; Rimm, David L; Velcheti, Vamsidhar; Schalper, Kurt; Madabhushi, Anant

Immune Checkpoint Blockade Outcome in Small-Cell Lung Cancer and Its Relationship With Retinoblastoma Mutation Status and Function

免疫检查点阻断疗法在小细胞肺癌中的疗效及其与视网膜母细胞瘤突变状态和功能的关系

Dowlati, Afshin; Abbas, Ata; Chan, Timothy; Henick, Brian; Wang, Xuya; Doshi, Parul; Fu, Pingfu; Patel, Jyoti; Kuo, Fengshen; Chang, Han; Balli, David

Tumor Immunity and Survival as a Function of Alternative Neopeptides in Human Cancer

肿瘤免疫和存活与人类癌症中替代性新肽的关系

Rech, Andrew J; Balli, David; Mantero, Alejandro; Ishwaran, Hemant; Nathanson, Katherine L; Stanger, Ben Z; Vonderheide, Robert H

Immune Cytolytic Activity Stratifies Molecular Subsets of Human Pancreatic Cancer

免疫细胞溶解活性可对人类胰腺癌的分子亚型进行分层

Balli, David; Rech, Andrew J; Stanger, Ben Z; Vonderheide, Robert H